D.E. Shaw & Co
OMGA

D.E. Shaw & Co’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

D.E. Shaw & Co’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,327
Closed -$58K – 5598
2022
Q2 		$58K Buy
15,327
+1,890
+14% +$7.04K ﹤0.01% 4820
2022
Q1 		$84K Buy
+13,437
New +$137K ﹤0.01% 5036

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

D.E. Shaw & Co's OMGA Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2022, closing a stake of 15,327 shares — an estimated $58K sold.

D.E. Shaw & Co first reported a position in OMGA in Q1 2022 and held it in 2 quarters. The position peaked at $84K in Q1 2022. 44 funds tracked by Wall St. Rank hold OMGA as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 15,327 Omega Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $58K.
  • D.E. Shaw & Co first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • D.E. Shaw & Co's Omega Therapeutics, Inc. Common Stock position peaked at $84K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.